Widge Anjali, Cleland John
London School of Hygiene & Tropical Medicine, London, United Kingdom.
Hum Fertil (Camb). 2009;12(3):144-52. doi: 10.1080/14647270903212156.
This article documents the context of Assisted Reproductive Technology/ies (ART) services and providers' perceptions regarding services offered in India. The objective is to facilitate understanding of critical issues and relevant concerns.
A postal survey conducted with a sample of 470 gynaecologists and in-depth interviews with 39 gynaecologists in four cities.
ART clinics have proliferated in cities and towns; they are commercialised and the quality of treatment is variable. Most providers perceived that patients lack knowledge about infertility and ART, costs are high, investigations unnecessarily repeated and success rates low. ART providers do not have clear selection criteria, some lack rigorous specialised training and infrastructure and most are deficient in record-keeping and counselling and lack transparency. Monitoring and regulation by appropriate authorities are also lacking.
Both providers and regulatory authorities need to look critically at exploitation of patients and commercialisation, excessive costs, lack of information, informed consent, and transparency, counselling, unethical practices, variations in quality of treatment and ensuring proper monitoring and regulation.
本文记录了印度辅助生殖技术（ART）服务的背景情况以及服务提供者对所提供服务的看法。目的是促进对关键问题和相关关注点的理解。
对470名妇科医生进行了邮政调查，并对四个城市的39名妇科医生进行了深入访谈。
ART诊所在城镇大量涌现；它们已商业化，治疗质量参差不齐。大多数提供者认为患者缺乏关于不孕症和ART的知识，费用高昂，检查不必要地重复进行，成功率低。ART提供者没有明确的选择标准，一些缺乏严格的专业培训和基础设施，大多数在记录保存和咨询方面存在不足且缺乏透明度。也缺乏相关部门的监督和管理。
提供者和监管部门都需要认真审视对患者的剥削和商业化、过高的费用、信息缺乏、知情同意和透明度、咨询、不道德行为、治疗质量差异以及确保适当的监督和管理等问题。
